Evidence map›Paper›PMID 37998192›Full record

ArticleEntropy (Basel, Switzerland)2023

A Framework for Enhancing Stock Investment Performance by Predicting Important Trading Points with Return-Adaptive Piecewise Linear Representation and Batch Attention Multi-Scale Convolutional Recurrent Neural Network.

Yu Lin, Ben Liu

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yu LinJoint Lab of Data Science and Business Intelligence, Southwestern University of Finance and Economics, Chengdu 610074, China.ORCID 0009-0003-8847-2466
Ben LiuJoint Lab of Data Science and Business Intelligence, Southwestern University of Finance and Economics, Chengdu 610074, China.ORCID 0000-0001-9833-1630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient stock status analysis and forecasting are important for stock market participants to be able to improve returns and reduce associated risks. However, stock market data are replete with noise and randomness, rendering the task of attaining precise price predictions arduous. Moreover, the lagging phenomenon of price prediction makes it hard for the corresponding trading strategy to capture the turning points, resulting in lower investment returns. To address this issue, we propose a framework for Important Trading Point (ITP) prediction based on Return-Adaptive Piecewise Linear Representation (RA-PLR) and a Batch Attention Multi-Scale Convolution Recurrent Neural Network (Batch-MCRNN) with the starting point of improving stock investment returns. Firstly, a novel RA-PLR method is adopted to detect historical ITPs in the stock market. Then, we apply the Batch-MCRNN model to integrate the information of the data across space, time, and sample dimensions for predicting future ITPs. Finally, we design a trading strategy that combines the Relative Strength Index (RSI) and the Double Check (DC) method to match ITP predictions. We conducted a comprehensive and systematic comparison with several state-of-the-art benchmark models on real-world datasets regarding prediction accuracy, risk, return, and other indicators. Our proposed method significantly outperformed the comparative methods on all indicators and has significant reference value for stock investment.

Indexed as

Batch Attention Multi-Scale Convolution Recurrent Neural Network (Batch-MCRNN)important trading points (ITPs)Return-Adaptive Piecewise Linear Representation (RA-PLR)stock markettrading strategy

Identifiers

PMID37998192
PMCPMC10670745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.